TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm).

Zhanwang XiangGuohong LiLuwen MuHaofan WangChuren ZhouHuzheng YanMingsheng Huang

Published in: Technology in cancer research & treatment (2023)

In patients with unresectable multiple nodular and large HCC (single nodular diameter of >5 cm), TACE combined with target therapy and immunotherapy is safe and effective.

Keyphrases

locally advanced
liver metastases
squamous cell carcinoma
stem cells
rectal cancer
mesenchymal stem cells